Dr. Sarah Wordsworth

Biography

Sarah Wordsworth is a Professor in the Medical Sciences Division at the University of Oxford, specializing in Health Economics. She joined the Health Economics Research Centre in January 2003, where she developed a robust research program focused on the economics of genetic and genomic technologies. Her research interests include the economics of translating high-throughput sequencing technologies, including whole genome sequencing in the context of rare diseases and cancer within healthcare systems. Additionally, she explores antimicrobial resistance (AMR), addressing the economic implications and barriers to implementing effective interventions. Her work also tackles methodological challenges related to trial-based economic evaluations in surgery, obesity, lung cancer surgery, cardiovascular disease, and eye diseases. Wordsworth leads significant policy work and is involved with the Health Economics Genomics England Clinical Interpretation Partnership (GeCIP), contributing to the UK's 100,000 Genomes Project, the largest sequencing initiative worldwide, which has sequenced 100,000 whole genomes from 70,000 NHS patients with rare diseases and cancer. A Senior Fellow at St. Anne’s College, she serves on the college's Governing Body, acts as a graduate advisor for DPhil and MSc students, and is part of the Centre for Personalised Medicine at St. Anne’s Wellcome Trust Centre for Human Genetics. She teaches a diverse range of undergraduate and graduate courses and is the Co-Director of the MSc in Precision Cancer Medicine.

Research Interests

Experience